Type 2 immunity is maintained during cancer-associated adipose tissue wasting.

Patrick J LenehanAssunta CirellaAmiko M UchidaStephanie J CrowleyTatyana SharovaGenevieve BolandMichael DouganStephanie K DouganMax Heckler

Published in: Immunotherapy advances (2021)

Wasting AT during the development of cachexia may not undergo drastic changes in immune composition like those seen in obese AT. Our approach provides a framework for future immunologic analyses of cancer associated cachexia.

Keyphrases

adipose tissue
insulin resistance
high fat diet
current status
weight loss
metabolic syndrome
type diabetes
obese patients
bariatric surgery
skeletal muscle